Skip to main content
. 2019 Dec 3;2019:9684175. doi: 10.1155/2019/9684175

Table 2.

Comparison of T and B cell proportions in CSF of patients.

NMDAR-AE HSVE TBM F P
WBC (/μL) [mean ± SD (range)] 32 ± 21.27 (3-83)#∗ 98 ± 46.32 (35-220) 155 ± 76.65 (65-278) 28.97 0.011
Lymph (%) [mean ± SD (range)] 46 ± 27.52 (30-99) 53 ± 38.24 (35-95) 48 ± 35.95 (12-90) 0.245 0.784
CD 3 cell (%) [mean ± SD (range)] 12 ± 9.47 (1-36) 14 ± 7.89 (2-27) 15 ± 9.56 (2-38) 0.632 0.535
CD4 cell (%) [mean ± SD (range)] 41 ± 25.24 (3-76) 59 ± 30.26 (12-89) 50.71 ± 20.50 (11-98) 2.66 0.078
CD8 cell (%) [mean ± SD (range)] 63 ± 31.59 (32-92)∗ 66 ± 32.56 (21-98) 16.36 ± 7.21 (8-25) 18.95 0.001
CD4 : CD8 ratios [mean ± SD (range)] 0.6 : 1 (0.4-1.3)∗ 0.9 : 1 (0.3-1.9) 3.2 : 1 (1.2-5.7) 59.96 0.002
CD20 B cell (%) 23 ± 12.59 (6.5-55)#∗ 3 ± 2.87 (1-12) 2 ± 2.08 (1-11) 55.84 0.001

Note: WBC (/μL) indicates the mean of the total CSF leukocyte counts; lymph (%) indicates the mean percentage of lymphocytes in the CSF. CD4 3 cell (%), CD4 T cell (%), CD8 T cell (%), and CD20 B cell (%) indicates each mean percentage in the CSF lymphocytes. CD4 : CD8 ratios mean the ratio between the percentages of CD4 and CD8 cells. #P < 0.05 vs. the HSVE group; ∗P < 0.05 vs. the TBM group.